<VariationArchive VariationID="1235" VariationName="NM_152419.3(HGSNAT):c.525dup (p.Val176fs)" VariationType="Duplication" Accession="VCV000001235" Version="6" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-05" DateCreated="2014-02-20" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16274" VariationID="1235">
      <GeneList>
        <Gene Symbol="HGSNAT" FullName="heparan-alpha-glucosaminide N-acetyltransferase" GeneID="138050" HGNC_ID="HGNC:26527" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p11.21-11.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="43140464" stop="43202855" display_start="43140464" display_stop="43202855" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="42995591" stop="43057969" display_start="42995591" display_stop="43057969" Strand="+" />
          </Location>
          <OMIM>610453</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_152419.3(HGSNAT):c.525dup (p.Val176fs)</Name>
      <CanonicalSPDI>NC_000008.11:43161468:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="43161468" stop="43161469" display_start="43161468" display_stop="43161469" variantLength="1" positionVCF="43161468" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="43016611" stop="43016612" display_start="43016611" display_stop="43016612" variantLength="1" positionVCF="43016611" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>V176fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.43016612dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.43016612dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.43161469dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.43161469dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009552.1" sequenceAccession="NG_009552" sequenceVersion="1" change="g.26021dup">
            <Expression>NG_009552.1:g.26021dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363227.2" sequenceAccession="NM_001363227" sequenceVersion="2" change="c.525dup">
            <Expression>NM_001363227.2:c.525dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350156.1" sequenceAccession="NP_001350156" sequenceVersion="1" change="p.Val176fs">
            <Expression>NP_001350156.1:p.Val176fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363228.2" sequenceAccession="NM_001363228" sequenceVersion="2" change="c.525dup">
            <Expression>NM_001363228.2:c.525dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350157.1" sequenceAccession="NP_001350157" sequenceVersion="1" change="p.Val176fs">
            <Expression>NP_001350157.1:p.Val176fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363229.2" sequenceAccession="NM_001363229" sequenceVersion="2" change="c.-309dup">
            <Expression>NM_001363229.2:c.-309dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152419.3" sequenceAccession="NM_152419" sequenceVersion="3" change="c.525dup" MANESelect="true">
            <Expression>NM_152419.3:c.525dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689632.2" sequenceAccession="NP_689632" sequenceVersion="2" change="p.Val176fs">
            <Expression>NP_689632.2:p.Val176fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA114869" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="610453.0006" DB="OMIM" />
        <XRef Type="rs" ID="483352895" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152419.3(HGSNAT):c.525dup (p.Val176fs) AND Mucopolysaccharidosis, MPS-III-C" Accession="RCV000001294" Version="3">
        <ClassifiedConditionList TraitSetID="328">
          <ClassifiedCondition DB="MedGen" ID="C0086649">Mucopolysaccharidosis, MPS-III-C</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2008-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152419.3(HGSNAT):c.525dup (p.Val176fs) AND not provided" Accession="RCV002243612" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152419.3(HGSNAT):c.525dup (p.Val176fs) AND multiple conditions" Accession="RCV002476908" Version="3">
        <ClassifiedConditionList TraitSetID="23316">
          <ClassifiedCondition DB="MedGen" ID="C0086649">Mucopolysaccharidosis, MPS-III-C</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4225287">Retinitis pigmentosa 73</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-14" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2014-02-20" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17033958</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18518886</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19479962</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="23316" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34236" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 73</ElementValue>
                <XRef ID="MONDO:0014687" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP73</ElementValue>
                <XRef Type="MIM" ID="616544" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16135" />
                <XRef ID="16135" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C4225287" DB="MedGen" />
              <XRef ID="MONDO:0014687" DB="MONDO" />
              <XRef Type="MIM" ID="616544" DB="OMIM" />
            </Trait>
            <Trait ID="2970" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MPS III C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-III-C</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+IIIC/4917" DB="Genetic Alliance" />
                <XRef ID="75238000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IIIC (Sanfilippo C)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopoly-saccharidosis type 3C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sanfilippo syndrome C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetyl-CoA alpha-glucosaminide n-acetyltransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 3C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS, TYPE IIIC</ElementValue>
                <XRef Type="MIM" ID="252930" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS3C</ElementValue>
                <XRef Type="MIM" ID="252930" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.</Attribute>
                <XRef ID="NBK546574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7073" />
                <XRef ID="7073" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536183</ID>
                <ID Source="BookShelf">NBK546574</ID>
              </Citation>
              <XRef ID="581" DB="Orphanet" />
              <XRef ID="79271" DB="Orphanet" />
              <XRef ID="C0086649" DB="MedGen" />
              <XRef ID="MONDO:0009657" DB="MONDO" />
              <XRef Type="MIM" ID="252930" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="328" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2970" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MPS III C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-III-C</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+IIIC/4917" DB="Genetic Alliance" />
                <XRef ID="75238000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IIIC (Sanfilippo C)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopoly-saccharidosis type 3C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sanfilippo syndrome C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetyl-CoA alpha-glucosaminide n-acetyltransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 3C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS, TYPE IIIC</ElementValue>
                <XRef Type="MIM" ID="252930" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610453.0010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS3C</ElementValue>
                <XRef Type="MIM" ID="252930" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.</Attribute>
                <XRef ID="NBK546574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7073" />
                <XRef ID="7073" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536183</ID>
                <ID Source="BookShelf">NBK546574</ID>
              </Citation>
              <XRef ID="581" DB="Orphanet" />
              <XRef ID="79271" DB="Orphanet" />
              <XRef ID="C0086649" DB="MedGen" />
              <XRef ID="MONDO:0009657" DB="MONDO" />
              <XRef Type="MIM" ID="252930" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21444" SubmissionDate="2014-02-12" DateLastUpdated="2014-02-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="610453.0006_MUCOPOLYSACCHARIDOSIS, TYPE IIIC" title="HGSNAT, 1-BP INS, 525T_MUCOPOLYSACCHARIDOSIS, TYPE IIIC" />
        <ClinVarAccession Accession="SCV000021444" DateUpdated="2014-02-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2008-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated Portuguese patients with MPS IIIC (252930), Coutinho et al. (2008) identified a 1-bp insertion (525dupT) in exon 5 of the HGSNAT gene, resulting in a frameshift and premature protein truncation. Two patients were homozygous for the mutation, and the third was compound heterozygous with a splice site mutation (610453.0007), which was predicted to result in nonsense-mediated mRNA decay.</Attribute>
              <Citation>
                <ID Source="PubMed">18518886</ID>
              </Citation>
              <XRef DB="OMIM" ID="252930" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HGSNAT" />
          </GeneList>
          <Name>HGSNAT, 1-BP INS, 525T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 525T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="610453.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUCOPOLYSACCHARIDOSIS, TYPE IIIC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5450031" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_152419.3:c.525dup|OMIM:252930;616544" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002799977" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152419.3:c.525dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="252930" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616544" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4924966" SubmissionDate="2022-05-16" DateLastUpdated="2023-03-04" DateCreated="2022-05-21">
        <ClinVarSubmissionID localKey="GDXSV:227764" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002513155" DateUpdated="2023-03-04" DateCreated="2022-05-21" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18518886)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HGSNAT" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:730875</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152419.2:c.525dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_106_20220511054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6129171" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4875621|MedGen:C4225287;C0086649" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003440702" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17033958</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19479962</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18518886</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val176Cysfs*16) in the HGSNAT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HGSNAT are known to be pathogenic (PMID: 17033958, 19479962). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with HGSNAT-related conditions (PMID: 18518886). ClinVar contains an entry for this variant (Variation ID: 1235). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HGSNAT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000008.10:g.43016611_43016612insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225287" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0086649" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5450031" TraitType="Disease" MappingType="XRef" MappingValue="616544" MappingRef="OMIM">
        <MedGen CUI="C4225287" Name="Retinitis pigmentosa 73" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6129171" TraitType="Disease" MappingType="XRef" MappingValue="C0086649" MappingRef="MedGen">
        <MedGen CUI="C0086649" Name="Mucopolysaccharidosis, MPS-III-C" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6129171" TraitType="Disease" MappingType="XRef" MappingValue="C4225287" MappingRef="MedGen">
        <MedGen CUI="C4225287" Name="Retinitis pigmentosa 73" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5450031" TraitType="Disease" MappingType="XRef" MappingValue="252930" MappingRef="OMIM">
        <MedGen CUI="C0086649" Name="Mucopolysaccharidosis, MPS-III-C" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="21444" TraitType="Disease" MappingType="Name" MappingValue="MUCOPOLYSACCHARIDOSIS, TYPE IIIC" MappingRef="Preferred">
        <MedGen CUI="C0086649" Name="Mucopolysaccharidosis, MPS-III-C" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4924966" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

